1. Home
  2. MIST vs DIBS Comparison

MIST vs DIBS Comparison

Compare MIST & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • DIBS
  • Stock Information
  • Founded
  • MIST 2003
  • DIBS 2000
  • Country
  • MIST Canada
  • DIBS United States
  • Employees
  • MIST N/A
  • DIBS N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • DIBS Catalog/Specialty Distribution
  • Sector
  • MIST Health Care
  • DIBS Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • DIBS Nasdaq
  • Market Cap
  • MIST 163.2M
  • DIBS 149.7M
  • IPO Year
  • MIST N/A
  • DIBS 2021
  • Fundamental
  • Price
  • MIST $2.61
  • DIBS $5.72
  • Analyst Decision
  • MIST Strong Buy
  • DIBS Hold
  • Analyst Count
  • MIST 3
  • DIBS 1
  • Target Price
  • MIST $6.33
  • DIBS N/A
  • AVG Volume (30 Days)
  • MIST 2.8M
  • DIBS 486.2K
  • Earning Date
  • MIST 11-12-2025
  • DIBS 11-07-2025
  • Dividend Yield
  • MIST N/A
  • DIBS N/A
  • EPS Growth
  • MIST N/A
  • DIBS N/A
  • EPS
  • MIST N/A
  • DIBS N/A
  • Revenue
  • MIST N/A
  • DIBS $89,422,000.00
  • Revenue This Year
  • MIST N/A
  • DIBS $2.87
  • Revenue Next Year
  • MIST N/A
  • DIBS $3.26
  • P/E Ratio
  • MIST N/A
  • DIBS N/A
  • Revenue Growth
  • MIST N/A
  • DIBS 3.49
  • 52 Week Low
  • MIST $0.63
  • DIBS $2.30
  • 52 Week High
  • MIST $2.75
  • DIBS $5.75
  • Technical
  • Relative Strength Index (RSI)
  • MIST 74.94
  • DIBS 75.77
  • Support Level
  • MIST $2.31
  • DIBS $4.59
  • Resistance Level
  • MIST $2.49
  • DIBS $5.42
  • Average True Range (ATR)
  • MIST 0.19
  • DIBS 0.43
  • MACD
  • MIST 0.06
  • DIBS 0.06
  • Stochastic Oscillator
  • MIST 95.50
  • DIBS 96.09

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About DIBS 1stdibs.com Inc.

1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.

Share on Social Networks: